Top Section/Ad
Top Section/Ad
Most recent
Shareholders sell down holdings in AutoStore and Orsted, as shipping company opens books ahead of Athens parallel listing
Deeply discounted financing allows embattled iron ore miner to restart Ukrainian production and shares to resume trading
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Food systems company’s largest shareholder raises €324m after shares rise on strong results and buyback
More articles/Ad
More articles/Ad
More articles
-
China Evergrande Group this week tapped the equity capital markets for HK$4.3bn ($554.9m), making its first primary share sale in five years. But the fundraising did not go as planned, with the embattled property developer nearly halving its initial target after investors called for a smaller deal. Jonathan Breen reports. -
Synairgen, the UK biopharmaceuticals company, has raised £80m from investors to fund the next stage of clinical trials for a treatment designed to alleviate the respiratory symptoms of Covid-19.
-
Wilhelm Beier, the German billionaire founder of Dermapharm Holding, has trimmed his stake in the pharmaceuticals company.
-
Covestro, the German chemicals company, priced a €447m capital increase on Tuesday night to partially refinance an acquisition. Investors supported the deal in large numbers, despite a rough night for secondary markets and an incredibly tight discount.
-
China Evergrande Group’s stock price plummeted on Wednesday after the issuer slashed an overnight share sale to nearly half its initial target, raising HK$4.3bn ($554.9m).
-
China Evergrande Group, a property developer, hit investors with a jumbo top-up placement on Tuesday, eyeing proceeds of up to HK$8.4bn ($1.1bn), according to a term sheet seen by GlobalCapital Asia.
